Lin Mei
Impact in
- Biomaterials top 0.02%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.1%
Papers in
-
- Nanoplatforms for cancer theranostics 110
- Graphene and Nanomaterials Applications 21
-
- RNA Interference and Gene Delivery 40
- Extracellular vesicles in disease 26
- Co-authors
- Xiaowei Zeng (91 shared papers)Wei Tao (35 shared papers)Laiqiang Huang (40 shared papers)Xiaoyuan Ji (26 shared papers)Si‐Shen Feng (12 shared papers)Zimu Li (19 shared papers)Hongzhong Chen (23 shared papers)Gan Liu (29 shared papers)
- Journals
- Journal of Controlled Release (15 papers)Advanced Functional Materials (14 papers)Acta Biomaterialia (10 papers)Biomaterials (10 papers)Acta Pharmaceutica Sinica B (8 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Lin Mei
266 papers receiving 19.8k citations
Lin Mei's Hit Papers
Peers
Comparison fields: 5 of 168
- Biomaterials 7.0k
- Pharmaceutical Science 1.6k
- Biomedical Engineering 9.8k
- Molecular Medicine 594
- Materials Chemistry 5.4k
Countries citing papers authored by Lin Mei
This map shows the geographic impact of Lin Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Mei more than expected).
Fields of papers citing papers by Lin Mei
This network shows the impact of papers produced by Lin Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Mei. The network helps show where Lin Mei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 276 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine Hit paper breakdown → | 2019 | 880 |
| 2 | The in vivo degradation, absorption and excretion of PCL-based implant Hit paper breakdown → | 2005 | 812 |
| 3 | Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics Hit paper breakdown → | 2016 | 799 |
| 4 | Recent progress in drug delivery Hit paper breakdown → | 2019 | 607 |
| 5 | Polydopamine‐Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments Hit paper breakdown → | 2018 | 533 |
| 6 | 2D Black Phosphorus–Based Biomedical Applications Hit paper breakdown → | 2019 | 522 |
| 7 | Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics Hit paper breakdown → | 2014 | 429 |
| 8 | A Novel Top‐Down Synthesis of Ultrathin 2D Boron Nanosheets for Multimodal Imaging‐Guided Cancer Therapy Hit paper breakdown → | 2018 | 404 |
| 9 | pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy Hit paper breakdown → | 2017 | 403 |
| 10 | Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation Hit paper breakdown → | 2019 | 358 |
| 11 | 2012 | 300 | |
| 12 | 2017 | 290 | |
| 13 | 2017 | 287 | |
| 14 | 2013 | 276 | |
| 15 | 2019 | 270 | |
| 16 | 2009 | 266 | |
| 17 | 2013 | 262 | |
| 18 | 2017 | 246 | |
| 19 | 2013 | 245 | |
| 20 | 2015 | 230 |
About Lin Mei
Lin Mei is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Materials Chemistry and Immunology, having authored 276 papers that have together received 20.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (110 papers), Nanoparticle-Based Drug Delivery (73 papers), RNA Interference and Gene Delivery (40 papers), Extracellular vesicles in disease (26 papers), Advanced Nanomaterials in Catalysis (25 papers), Graphene and Nanomaterials Applications (21 papers), Immunotherapy and Immune Responses (20 papers) and Dendrimers and Hyperbranched Polymers (18 papers). The work is most often cited by research in Biomaterials (7.0k citations), Pharmaceutical Science (1.6k citations), Biomedical Engineering (9.8k citations), Molecular Medicine (594 citations) and Materials Chemistry (5.4k citations). Lin Mei has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiaowei Zeng, Wei Tao, Laiqiang Huang, Xiaoyuan Ji, Si‐Shen Feng, Zimu Li, Hongzhong Chen, Gan Liu, Han Zhang and Cunxian Song. Their work appears in journals such as Journal of Controlled Release, Advanced Functional Materials, Acta Biomaterialia, Biomaterials and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.